Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')

Ann Oncol. 2023 Jun;34(6):553-554. doi: 10.1016/j.annonc.2023.03.003. Epub 2023 Mar 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma* / drug therapy
  • Adenocarcinoma* / therapy
  • Chemoradiotherapy
  • Esophageal Neoplasms* / drug therapy
  • Esophageal Neoplasms* / therapy
  • Follow-Up Studies
  • Humans
  • Neoadjuvant Therapy

Supplementary concepts

  • Adenocarcinoma Of Esophagus